Archean Chemical Industries (ACI) Q1 25/26 earnings summary

Executive summary

• Q1 FY26 revenue grew 30% year-on-year to INR 2,915 million, driven by a steady product mix, strong exports, and operational resilience despite industry volatility.

• Exports accounted for 81% of operating revenue, reflecting robust international demand.

• Strategic investments and acquisitions in bromine derivatives, semiconductors, and energy storage are underway to support future growth.

• Bromine business maintained growth with limited price volatility due to long-term contracts; industrial salt business remained stable.

• Profit after tax (consolidated) for the quarter was INR 401.4 million, compared to INR 448.4 million in the same quarter last year.

Financial highlights

• Standalone Q1 FY26 revenue: INR 2,915 million (up from INR 2,234 million in Q1 FY25); consolidated revenue: INR 3,005.9 million (up from INR 2,223.9 million in Q1 FY25).

• Standalone EBITDA: INR 958 million (13% YOY growth), margin near 33%; consolidated EBITDA: INR 863.2 million.

• Standalone net profit: INR 518.5 million (up from INR 484.6 million); consolidated net profit: INR 401.4 million.

• Standalone EPS: INR 4.20; consolidated EPS: INR 3.25.

• Industrial salt sales: 1.1 million tons; bromine sales: 4,054 tons; SOP: 52 tons.

Outlook and guidance

• Long-term contracts expected to sustain bromine and salt volumes; order book remains full.

• Guidance for FY26: 22,000–25,000 tons bromine, 4.5 million tons salt; SOP to contribute meaningfully in H2 FY26.

• Oren Hydrocarbons (Idealis Mudchemie) expected to start commercial production in Q3, with INR 150 crore revenue target for FY26, though ramp-up may be slower.

• Awaiting final government approval for a new semiconductor plant in Odisha.

• Strategic investments are expected to drive long-term value and support entry into new high-growth sectors.